Hemoglobin Oxygen Therapeutics LLC (HOTI)

HOTI Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.44	0.44	0.36
Cash & Cash Equivalents	0.44	0.44	0.36
Cash Growth	-	24.28%	-
Other Current Assets	0.14	0.14	0.14
Total Current Assets	0.59	0.59	0.5
Property, Plant & Equipment	4.48	4.48	4.48
Goodwill and Intangibles	0.93	0.93	1.53
Other Long-Term Assets	0.04	0.04	0.55
Total Long-Term Assets	5.45	5.45	6.56
Total Assets	6.03	6.03	7.06
Accounts Payable	1.73	1.73	1.64
Deferred Revenue	0.38	0.38	-
Current Debt	8.12	8.12	4.28
Other Current Liabilities	3.86	3.86	1.91
Total Current Liabilities	14.09	14.09	7.84
Long-Term Debt	1.09	1.09	4.35
Other Long-Term Liabilities	0.11	0.11	0.73
Total Long-Term Liabilities	1.2	1.2	5.08
Total Liabilities	15.28	15.28	12.91
Total Debt	9.21	9.21	8.63
Debt Growth	-	6.72%	-
Shareholders' Equity	-9.25	-9.25	-5.86
Net Cash / Debt	-8.76	-8.76	-8.27
Working Capital	-13.5	-13.5	-7.33

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).